Pfizer Inc. et al v. Cipla Limited
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and Wyeth LLC |
Cipla Limited |
1:2023cv00909 |
August 18, 2023 |
US District Court for the District of Delaware |
Christopher J Burke |
Gregory B Williams |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on October 13, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
|
Pro Hac Vice Attorney Joshua I. Miller and Louis H. Weinstein for Cipla Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
|
Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein and Joshua I. Miller - filed by Cipla Limited. (Taylor, Daniel) |
|
Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, and Seth R. Bowers - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
|
Filing 10 ANSWER to #1 Complaint, with Additional Defenses by Cipla Limited.(Taylor, Daniel) |
|
Filing 9 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cipla Limited. (Taylor, Daniel) |
Filing 8 STIPULATION TO EXTEND TIME for Defendant Cipla Limited to answer the complaint, from September 11, 2023 to September 25, 2023 - filed by Cipla Limited. (Taylor, Daniel) |
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
Filing 7 SUMMONS Returned Executed by Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC.Cipla Limited served on 8/21/2023, answer due 9/11/2023. (Dellinger, Megan) |
Filing 6 Summons Issued as to Cipla Limited on 8/18/2023. (mpb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (mpb) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,770,441 B2. (mpb) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/10/2023. Date of Expiration of Patent: 8/31/2035.Thirty Month Stay Deadline: 11/3/2026. (mpb) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
Filing 1 COMPLAINT filed with Jury Demand against Cipla Limited ( Filing fee $ 402, receipt number ADEDC-4205121.) - filed by Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.